- MyIllumina
- Tools
The DNA Test Panel is a SNP-based tool for pre-screening DNA samples for assay performance before conducting studies with larger numbers of loci. It contains 360 SNP loci distributed across the genome chosen from the LinkageIVb Panel, including neutral loci outside of RefSeq transcripts and evolutionarily conserved sequences not likely to be associated with disease that may be used as a genomic control.
The panel also contains Ancestry Informative Markers (AIMs) chosen from three populations that may be used to assess potential stratification in study samples.
- SNP sequences are optimized for Illumina's proven GoldenGate Genotyping Assay protocol
Catalog IDs: GT-17-222
Product Literature
| DNA Test Panel |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.